<DOC>
	<DOCNO>NCT01597895</DOCNO>
	<brief_summary>The purpose study determine effect telaprevir boceprevir pharmacokinetics maraviroc .</brief_summary>
	<brief_title>Estimate Effect Telaprevir Boceprevir Maraviroc Pharmacokinetics Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Maraviroc</mesh_term>
	<criteria>Healthy male and/or female subject . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 . Total body weight &gt; 50 kg ( 110 lb ) . Use prescription nonprescription drug dietary supplement within 7 day 5 halflives ( whichever longer ) prior first dose study medication . Use tobacco nicotinecontaining product excess equivalent 5 cigarette per day . Positive result HIV1 , HIV2 , Hepatitis B serology ( HbsAg , HbcAb ) anti hepatitis C virus serology ( determine multi antigen EIA ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>maraviroc</keyword>
	<keyword>boceprevir</keyword>
	<keyword>telaprevir</keyword>
	<keyword>drug interaction</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>HIV</keyword>
</DOC>